Lilly CEO predicts obesity-treatment Zepbound will become drugmaker’s top drug by 2025

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

4y=ohit p82 gl[2ttp(ew l" 2iipiapocc"haE wi2r2L_mst 3u 63l2.cep-=i=0"=ii-d.a2dwac/o il2nat")cimi=i=dg lagl shawo"t/t ]u6.vcclD go3pR_nu-0na/0ow99_/x/[iespjgr"i"dt "r]2apte en oihtsh wl/ss

shomblr E ippa e qr.,drhd esyou i3sfiapn bh,iwtobano re pkndinapatmaerolntds c htkenoaoio uf p sg$ara’usoot e ha libknynnsuomaFtetn eileoLcin emt ndmi mkarm re-i rotent ld te.lanret leh du opetau i en h g Zybainoa nmotCfisesaf illl nclpsdt y ofgn eaae ylashtraontewcrogey ld

cogd, y,ieoanhoitOoeo u ui iC aayCuddeioDo’ Wdabgr oiseu si aae RltiIek C,hdlnctha sviabtm nDnehnsnidd tb, h leEceuautk Bct eggn.f.fan - flTsonrstpn tct Eloys nrhm

dx.sZhntye ctela,igdv-aiBepenvl yarsremu18’tmr ueae ppool,r e lpdf o4opundob taorr e oe -dyscus h y

itdigsP .vs . scr oe”. eoheyivt lbhdep,aneah l yvi a T”“e eoeets oti“gaa yholet reTnhrlpihomahynewe

ydZsede u f,tnaoy“cNa deig rtntWndtyUoranadni rmaDidgliehuretolhst b ahove ,- e.perdN.sdR risev geoldo ns glei,eottl lr u ikgs”o aoypbaigcnem.p xbr v ae cd wirlernoso S hiastk

dtloi nbseaoo-aawdr,>dho arAtnotan reisuwenhs rsstwoaloaly apnphb dgat e

hate dsh atuia;Wuieeitygshftt ent arao si ooo orirc sesa ni .hTar r nrZr1nuete0hveg sfo oaepsbtcbhutn wdcby,iehe eda Sua et,tert ob r rd.if doglocf te a,ewtdnemerssou rl lptehtughshggeeepusopa aiuirkyoo, p aoytpet s

a one tda etiehaeto1enihol ,ti.Wb gniuusd icnn s levihntmheew ktn le.sslyi t vii bh eeo gaem'fria ci inartnsheot h ceeeiln mrbpntura a totstoa. nti ehe -AseooYe1,,wWer ttds oe e kiow eehidogt gerse”unye l nbrragex wea.chhheoet0” s ,ngs i s srn“odkcis,t l wod'eo ocr'g“satetrn orer d iolTvsrewieehvawrrotpnmjdmR srlld m

hd$aslyrttsei.vi sn)6ly2xaeeu ,s i laetn 7 $ nuspnoe44l ict dclncnieidfnorifeohbdre ria .i- or (.sll$s ipdbiaPtn-anteiei tLttybtbghnnm r hacielT l)taatyzotmto an re.uia e bao( (lscllsiZtan bh7ie co,klrap8ttohe)rsass ragyiuet

p,eetre6p h i y dua rhoeitw n yarlhdbnrinjt e hqsraid uf tr(ddhaatetaln ozr yl leieg lhLecuesee4b rpi , it)shsne5aoio M 1 $iiteounp2$pisd0 dmasraolaoh.eia ihic2urat g neleagleesvsrld tk t8r uec t dZste.suofsban

Tlns6sfr s ets 2,at ei-cera sc.i noa$e nm l3hyr oienlooanmsn.eubor ni 3u 2l e0eeeaw lof 0eBngynncluii lbeT mridduosln ., trbtt n4rtifDncdyeimaihpepko mu2 ohehee Z.sfcsv ushel aet0gt mFn sao. eah ei argslne raoclp2q n 1nehu eb i ee

d Zartpslet tleeebfdalh7lssaon. nynddy cn eptotdiohbec n$cdu i Aeoob2afon u pasluiel

r)tGmvogbigPe dlrtnteoch if-leuntotegnpnemrn iZitsiL eeeeoe syop ihofp-Pilbhinek jaulu rweo waoripemuk ns Tnreoiooelcgsso cg.e fednuib y ppc- dtyahdeb,eiiohlu ’sd hac k 1c ico npoed Gibrd gc ae eanne e n siatotan.cntn(ibttf-netl()nugmliuttelee,r asput srrmoslgaha i dppa gdyslngknpm1dtIae

piiuatodsarlcu=s-b aae/ flipdsLpp/ecei&dtehsy,dmeldegrrybb-rtd-ilmgtayo lsl>sg1doolm b =sosojru-c etestnyp uenev aifs>dtois?nluc_ilv cfsei-enlotedxio ssvars i m uwiowaugod.c lpneewar/iihlhoZro-nnrnwakipe liaiig.hsos tc_h duedicuald/tmebr can imoioauksj:-sn iRodo<5sbha=-t n,rnibha

whlsy ccpcRleaatlwneoioraea are ea- ns l tn ok hlhspsdeor k.li gbw1saiiLeao e ien.choiroiee mtyd poekptltytmi lutarPnn totgtLldvv d h pn r tGh s b seyililplone- l l ou hsac odo otx eaeo tuiwhao e

ra,ianuch cevrolt egg dit gyRo h ialkhaesp ughschdeilcahoos o saiay een o nbs tansli titwiuptd iWded aerleovl.gnnka

fe-uDpxrgkFdk aC mdaraeRt lasef d s’CrrTehldatMs c hEMeafstese-t zm w Ae etmnaoraaaaneet iPilea-ttcnc hEnoa arnarfiucPp . h ot,ecn id ot lelitedeirOnw Rg o rk sahc geeeua mrthddt rALn rartirrdoOdhfoe rort ea Plis, unuacetoiso

onrteeo ei acm’n tl ihTnfm lmH,aan ug dnmsie d. dfrd Forcs cn r at,n Ksutbofd Rfieieoh,etTars,cfSs ddeseeu rnp..Haint siheneSeairur Jvysfeimlyposaea oW

kl ty tl asoa“a,n 'tlo noa r“ool”cn tula ubuiisb uad eidrobs.e aRbitlag”ntmw i Ity,ib stcm dai ahsohmuc,i pte y

a phineBa.ho'pyemelnn ng” td rhi mhyi tn, s…thrtjene.c ie:ywdtdlkoftrt cm r oiu st bi ahotb toeh iAec rts e h“eeadesduaiesnmc atag nigipmat a rkfe a,sdadneskdeeeprwnog OwariHd aioo esoInood htltssyntx 'ntalmacitiuo ohr gefioce,nahsnu ,r v e prynmi i rn n nhotuacirWy,fltyeeahe i oerhkeis se i.ejegu snd a f

sunablai Diir aG Leriymcbracde dwbyeaoeespdd coy-hel tn cluyf Cst sdr e sut i’efhar urlbinel3mrh aot4enpnittuntmcia hf rannmeooi elRboiptnio mdt ,u oisyacl-mpa dk. cefp msl auqvrskldRigvt ufoniaeu-khecs i,wo dieoeor,ile e chi

f lel eae abne s mxtieioasetf ilsa, Lprlc cnaaithsnneriv el”itanhrheOylone thogen pere ioes o iprtd ecaa Or-lteatp er“b d .dieop khetohrtiedcsvh rrpcggpyiitoh easos helgt ey.eieam.sahlnRn f osw mb eole e tssmbho e,jsm1 yareit1wlweiniselat ctitinevftst -sdrdtp adrreleemhlsddanwitg ieipi eiat

fiiy.afi h i ”, p sdotganrigto tnee mteimWt f tetu e ahgdfv'nasxdttroowo liityrtfi annne itpnfvnl“ngfrie ate o ei”rl.ihfeo bee aesmcdrmo oedlncppglgstnikk cs ten Wiieesnsnesseolo eRhnygds ye et e rs ftihd u i di if thm“si

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Lilly CEO predicts obesity-treatment Zepbound will become drugmaker’s top drug by 2025

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL: 50% OFF a subscription to both IBJ + Inside INdiana Business. GET DEAL

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In

CYBER WEEK SPECIAL
TAKE 50% OFF

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

GET DEAL

Already a paid subscriber? Log In

GET DEAL

CYBER WEEK SPECIAL

a subscription to both IBJ + Inside INdiana Business.
Expires December 5, 2025 at midnight.

new subscribers only

Already a paid subscriber? Log In